LungLife AI, Inc.

LSE : LLAI

LungLife AI, Inc., a diagnostic company, researches and develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology in the United States and the People's Republic of China. The company engages in developing LungLB, a blood-based test to stratify cancerous and benign lung nodules identified by CT scan. The company was formerly known as Cynvenio Biosystems, Inc. and changed its name to LungLife AI, Inc. in May 2019. LungLife AI, Inc. was incorporated in 2009 and is based in Thousand Oaks, California.

Information

Website
https://lunglifeai.com
Sector
Healthcare
Industry
Diagnostics & Research
Type
Common Stock
Country
United States

Price

GBp 11.50

Symbol

LLAI

Type

Common Stock

Previous Close

 :

11.50

52 Week Range

 :

11.12 - 98.00

Volume

 :

0.00

Average Volume

 :

8,772.00

High

 :

11.50

Low

 :

11.50

Change

 :

0.00

Percent change (%)

 :

0.00

Stakeville

A Free-to-Play Trading Game. Sharpen your skills, trade stocks, and have fun!

Play Now
Getting Started
Get Your Free Account For Educational Purpose Knowledgebase
Legal
Cookie Policy Privacy Policy Terms & Conditions
Customer Service
Help Desk Support Stakeville Newsletter
Stay Connected
Contact Us Official Blog About Us
Disclaimer: Stakeville is a simulation trading game. All trades and stock prices are fictional and do not reflect real-world markets. This game is for entertainment purposes only and does not involve real financial transactions. Read more...